The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression
Biomolecules · 24.10.2025 · 15 (11) · 1506
DOI: 10.3390/biom15111506 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.10.2025. Verfasst von Jiayi Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China. Hauptthemen laut MEDLINE: NK Cell Lectin-Like Receptor Subfamily K, Killer Cells, Natural, Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Green Seedling Talent Program, Guangxi University Science and Technology Multiplication Program for Cultivating Young Backbone Innovative Talents.
Abstract (Originalsprache)
Natural killer (NK) cells are the main cytotoxic lymphocytes of the natural immune system, which play an important role in tumor immune surveillance and anti-viral response. The surface receptor NKG2D can recognize NKG2D ligands on the surface of tumor or metabolism-stressed cells, thereby activating immune responses and mediating cytotoxicity and anti-tumor activity of NK cells. However, NKG2D-positive NK cells are regulated by metabolites, and play a negative role in metabolic diseases. Various metabolites, including lipids, reactive oxygen species (ROS), glucose and amino acids, regulate NKG2D expression and NK cell activity and decide the immune microenvironment of pathological tissue. Thus, targeted therapies based on NKG2D-positive NK cell have entirely different strategies in the treatment of tumor or metabolic diseases. This article focuses on the metabolic regulation of NKG2D-positive NK cells and their opposite roles in disease progression, including of cancer and metabolic disease. In the future, in-depth studies of the regulatory mechanisms of the NKG2D signaling pathway by metabolites and the optimization of the safety and efficacy of targeted therapeutic strategies will lead to new breakthroughs in the treatment of tumors and metabolic diseases, providing patients with more effective treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.
ORCID-Profile: Sulan Luo, Kunpeng Liu
Förderung
- National Natural Science Foundation of China
- Guangxi Green Seedling Talent Program
- Guangxi University Science and Technology Multiplication Program for Cultivating Young Backbone Innovative Talents
- Science and Technology Program of Guangzhou
- Guangxi Bagui Youth Talent Training Program
Zitieren
APA
Tang, J., Lu, Y., Chen, M., Wu, Q., Li, Y., Qin, Y., Liang, S., Luo, S., & Liu, K. (2025). The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression. Biomolecules, 15(11), 1506. https://doi.org/10.3390/biom15111506
Vancouver
Tang J, Lu Y, Chen M, Wu Q, Li Y, Qin Y, et al. The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression. Biomolecules. 2025;15(11):1506. doi:10.3390/biom15111506
BibTeX
@article{Tang2025,
author = {Tang, Jiayi and Lu, Yaqi and Chen, Min and Wu, Qifan and Li, Yifei and Qin, Yingqiao and Liang, Shaomei and Luo, Sulan and Liu, Kunpeng},
title = {The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {11},
pages = {1506},
doi = {10.3390/biom15111506}
}
EUVIMED